secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2021-08-27T23:59:59+00:00
Accession:  0001564590-21-046031
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CSO Jane Gross to resign Sept 14, 2021; will consult through Dec 31, 2021
-------------------------------------------------------------------------

- Jane Gross resigns as Chief Scientific Officer effective Sept 14, 2021; transitions to consultant through Dec 31, 2021.
- Receives lump-sum $166,000 cash payment by Jan 7, 2022; hourly rate for transition hours beyond stated limit.
- Vested stock options exercisable for 90 days from Jan 1, 2022.
- Non-compete and non-solicitation obligations for 12 months following last day of employment.
- Company has commenced search for a new Chief Scientific Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000156459021046031/0001564590-21-046031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000156459021046031/apvo-8k_20210825.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-046031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer